RAVN
Leadership questions, marketing questions, and quick trends, answered in plain language with sources. RAVN builds the charts and slides too.
Ask About Early AccessSee the market move. Decide where to move next.
Commercial intelligence for manufacturers. Research intelligence for sponsors and CROs.
Data network coverage
- 80M+
- de-identified patients
- 20,000+
- eye care locations nationwide
- 30K+
- eye care professionals
Tools built for specific questions.
FitShare
See exactly where you're winning and losing share.
- Share by region/local
- Source of volume analysis
- Market shift analysis
Learn more
Viking Signals
Help your team show up where it's relevant, with something useful to offer.
- Clear priorities.
- Signal strength scoring
- Next best action
Learn more
Eye care is all we do.
Most eye care market data comes from surveys, claims, or shipments. Viking is built from what actually happens, then turned into answers you can act on.
Both sides of eye care
Optometry and ophthalmology in one view.
Real, not recalled
Built from real-world activity, not what people remember or what was shipped.
Answers, not just data
We tell you what moved, why it matters, and where to focus.
From first exam to long-term care
Viking follows the patient journey through eye care in de-identified form, so manufacturers can see how products are chosen, fitted, and continued over time, not only what was sold.
How the industry uses Viking
Leading eye care manufacturers use Viking every month to track share by brand, product type, and region.
An ophthalmic pharmaceutical company uses Viking Signals to decide where to focus its commercial team.
A leading ophthalmic CRO used Viking's site analysis to strengthen a study bid.
Manufacturers
Grow share and serve practices better.
Stop relying on lagged claims data. Use monthly-refreshed, aggregated market signals to prioritize the right opportunities and measure performance accurately.
Challenges We Solve
1
Blind Spots
Claims data misses much of the picture and lags by months.
2
Misplaced Effort
Field time goes where it adds the least because plans are built on outdated estimates.
3
Pricing Blind Spots
You can't see how average price per unit varies by region and competitor.
What You Gain
Sharper Focus.
Identify high-value opportunities based on aggregated market signals, not estimates.
Faster Decisions
Monthly data refreshes help you catch trends before they become problems.
Defensible Narrative
Board-ready data that stands up to scrutiny.
Recommended Momentus Stack
Clinical Research Sponsors and CROs
_1791232379543-Dj4Hfpiv.png)
Stronger feasibility, sharper site selection.
Feasibility and protocol design, site selection, and patient identification for ophthalmology trials, for sponsors and the CROs that support them.
Challenges We Solve
1
Uncertain Feasibility
Bids and site selection built on incomplete or self-reported data.
2
Enrollment Risk
Sites that look good on paper but under-deliver on patient volume.
3
Enrollment Uncertainty
Patient identification has to stay inside each site's control, with no surprises.
What You Gain
Real patient counts
Aggregated, region-level estimates of eligible patients, before you commit.
Sharper site selection
A ranked list of sites, with proven performers and new options clearly separated.
Patient identification
Each site identifies its own eligible patients and approves every patient-facing step.
Recommended Application
Viking ClinicalMarket Studies
For executives who need a defensible answer to a specific question:
Market Studies: Custom IntelligenceAre you an eye care practice? Visit Practices.
Bring us your next market or research decision.
Talk to Viking about the right Momentus solution for your role and goals.
Book a Demo